Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
IMDX Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-19.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-12.90%
IMDX Stock Analysis
IMDX
PE Ratio:
IMDX
PEG Ratio:
Not Available
IMDX
Forward EPS Growth (12 month):
0.00%
IMDX
PS Ratio:
83
IMDX
PSG Ratio:
Not Available
IMDX
Forward Revenue Growth (12 month):
0.00%
IMDX Articles
No data was found